InVivo Therapeutics (NSDQ:NVIV) said yesterday that it’s laying off nearly 40% of its workforce, pausing a clinical trial and cutting two R&D programs as it tries to get its a pivotal study back on track. The Cambridge, Mass.-based company, which is developing a scaffold implant to treat traumatic spinal cord injuries, last month suspended its 16-patient […]
Zimmer Biomet prez, CEO Dvorak unexpectedly resigns | Personnel Moves, July 12, 2017
Zimmer Biomet (NYSE:ZBH) said late yesterday its prez and CEO David Dvorak has resigned from his position at the head of the company, effective immediately, to be replaced on an interim basis by senior VP and CFO Daniel Florin until a permanent successor is named. The Warsaw, Ind.-based company said it is retaining “a leading executive search […]
iCad deals VersaVue software, DynaCAD to Philips InVivo unit for $3.2m
iCad (NSDQ:ICAD) said yesterday that it agreed to deal its VersaVue software and DynaCAD breast and prostate imaging devices to Royal Philips‘ (NYSE:PHG) InVivo unit for $3.2 million. Nashua, N.H.-based iCad said the Dec. 16 deal includes a holdback reserve of $350,000. The deal is expected to close by Jan. 31, 2017; if it doesn’t close by […]
MassDevice Network
@MassDevice
LinkedIn
YouTube